Skip to main content

MMS

Stock
Industrials
Specialty Business Services

Performance overview

MMS Price
Price Chart

Forward-looking statistics

Beta
0.64
Risk
26.41%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

with a focus on more effective and efficient government programs, maximus has operated under our founding mission of 'helping government serve the people'​ since 1975. our 16,000+ professionals deliver high-quality business process and technology solutions, as well as specialized consulting services for government agencies across north america, australia, the united kingdom and saudi arabia. together, we offer better solutions that lead to better lives for participants of health, welfare-to-work, and child support programs.

Company info

SectorIndustrials
IndustrySpecialty Business Services
Employees29K
Market cap$5.2B

Fundamentals

Enterprise value$5.5B
Revenue$5.4B
Revenue per employee
Profit margin5.56%
Debt to equity97.23

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$4.99
Dividend per share$1.20
Revenue per share$90.60
Avg trading volume (30 day)$30M
Avg trading volume (10 day)$31M
Put-call ratio

Macro factor sensitivity

Growth+6.5
Credit+25.9
Liquidity-12.5
Inflation+0.5
Commodities+2.0
Interest Rates-1.1

Valuation

Dividend yield1.67%
PEG Ratio13.25
Price to sales0.75
P/E Ratio13.25
Enterprise Value to Revenue1.01
Price to book2.44

Upcoming events

Next earnings dayAugust 5, 2025
Next dividend day
Ex. dividend dayMay 15, 2025

News

XRAY vs. MMSI: Which Stock Is the Better Value Option?

Investors interested in Medical - Dental Supplies stocks are likely familiar with Dentsply International (XRAY) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research (July 18, 2025)
Should Value Investors Buy Maximus (MMS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research (July 7, 2025)
After Plunging 6.1% in 4 Weeks, Here's Why the Trend Might Reverse for Maximus (MMS)

Maximus (MMS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Investment Research (June 20, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free